# From university research to commercial reality: 9 questions every founder should ask *Developing a promising technology is one thing. Establishing the legal rights, commercial capabilities and financial resources to turn it into a successful business is another.* Universities produce extraordinary research, but not every promising discovery becomes a commercially successful product or service. The journey from laboratory to market involves decisions researchers may not have had reason to consider during technology development. Who owns the invention? Can the software be patented? How can potential investors be approached without disclosing valuable information, and how much should a fledgling company spend protecting intellectual property when its resources are already stretched? These questions are closely connected. **The challenge isn't simply to protect an invention, but to build a business with the legal rights, commercial freedom, and practical capability to exploit it.** For researchers considering a university spinout or other commercialisation opportunity, nine questions deserve particular attention. **1\. I developed the technology at university. Doesn't that mean I own it?** Not necessarily. The person who creates intellectual property is not always the person or organisation legally entitled to own or commercialise it. In Australia, ownership of university-developed intellectual property depends on several factors, including employment arrangements, university intellectual property policies, research funding agreements and contracts with external collaborators. The position of an academic employee may differ considerably from that of a student, visiting researcher or independent contractor. A further distinction exists between ownership and the right to use intellectual property. A university may own the underlying invention while granting a spinout company an exclusive licence to commercialise it in particular markets, subject to agreed conditions. Those conditions can materially affect the business, including through royalties, equity participation, development milestones, territorial restrictions and rights to sublicense or transfer the technology. **For a prospective investor, the critical issue is not necessarily whether the startup owns the intellectual property outright, but whether it controls the rights necessary to execute its business plan.** Before establishing a spinout, founders should clarify who created the relevant intellectual property, who owns it, what pre-existing technology it relies on, and whether third parties have contractual rights that affect its commercial use. **2\. Can I patent software, or does copyright only protect it?** Software may attract several forms of intellectual property protection, but those rights protect different aspects of the technology. In Australia, copyright generally arises automatically in original software code and protects its expression, not the underlying idea, functionality, or commercial concept. Patents operate differently. Certain computer-implemented inventions may qualify for patent protection where they satisfy the relevant legal requirements, but implementing an abstract idea or business method using ordinary computer technology is not necessarily sufficient. The distinction matters because copyright generally does not prevent a competitor from independently developing different code that performs similar functions. A patent, where available and appropriately drafted, may provide broader protection against commercial exploitation of the claimed invention. Whether pursuing a patent is worthwhile depends on the technical contribution, available prior art, likely scope of protection and commercial importance of the invention. A startup should also consider whether confidential know-how, copyright, contractual protections, or a combination of these offers a more proportionate strategy. **3\. How do I speak to investors or commercial partners without giving away my idea?** Researchers often face a tension between demonstrating the value of their work and preserving its confidentiality. Investors and commercial partners need sufficient information to assess an opportunity, but premature disclosure can undermine trade secret protection and jeopardise patent rights. A non-disclosure agreement can be useful, particularly when discussing confidential technical details with prospective commercial partners. However, investors may be reluctant to enter confidentiality agreements during preliminary discussions, especially where they regularly encounter similar technologies. A staged approach is often more practical. Initial discussions can focus on the commercial problem, the proposed solution's benefits, market opportunity, competitive advantages, and evidence supporting feasibility, without disclosing the confidential technical information needed to reproduce the invention. More detailed disclosure can follow once we establish suitable protections and commercial arrangements. Researchers should also consider the timing of academic publications, conference presentations, demonstrations and thesis disclosures, particularly where patent applications have not yet been filed. **4\. If our technology is genuinely new, are we free to sell it?** Not necessarily. One of the most consequential distinctions in intellectual property law is between having a patentable invention and having *freedom to operate*. A company may develop a novel invention and even obtain its own patent while still infringing another party's existing patent when manufacturing, using or selling its product. A patent is primarily a right to exclude others from exploiting the claimed invention, not permission to commercialise it. Freedom-to-operate analysis examines whether relevant third-party rights could interfere with the company's intended activities in particular jurisdictions. Depending on the findings, a business may need to modify its technology, obtain a licence, reconsider its target markets or assess the legal strength and remaining duration of existing patents. The same forward-looking discipline should inform branding decisions. Registering a company name, securing a domain name, or developing an attractive logo does not necessarily grant the right to use that brand commercially. Searching existing trade marks, business names and relevant market activity before investing heavily in branding can avoid expensive disputes or rebranding exercises. Importantly, a business intending to expand overseas should consider whether its proposed brand and technology can be used in those markets, rather than assessing intellectual property risks solely within Australia. **5\. I've developed an app. How do I protect it?** This question is common among technology founders, but it can mask a deeper issue. **An app is not necessarily the business; it may simply be the mechanism through which the business delivers value.** An app's source code, visual elements, branding and underlying technology may attract different forms of protection. However, preventing someone from copying particular code is not the same as preventing competitors from offering a comparable service. Consider an app that connects researchers with industry partners, supports clinical decision-making or helps businesses manage regulatory obligations. Its commercial success may depend less on the originality of its interface than on customer relationships, proprietary datasets, specialised expertise, distribution channels or integration into existing workflows. The appropriate intellectual property strategy therefore depends on understanding the broader business model. Founders should ask what customers are actually purchasing, why they would choose the product over alternatives and which assets make that advantage difficult to reproduce. Protecting the software remains important, but protecting the commercial advantage it creates may be far more valuable. **6\. We have an excellent technical team. Is that enough to commercialise the research?** Technical capability and commercial capability are different disciplines. A team may have exceptional research expertise but lack the experience to identify customers, develop pricing strategies, negotiate distribution arrangements, manage regulatory requirements, or build a sustainable sales operation. This does not diminish the value of the research. It recognises that **developing a technology and building a business around it require different kinds of judgment**. Early-stage ventures should assess whether their teams collectively possess the commercial, financial, operational and managerial capabilities needed to execute their plans. In some cases, the answer may be to recruit an experienced commercial co-founder, engage specialist advisers, or partner with an established business rather than immediately building an independent company. A commercially promising invention does not automatically require a venture-backed startup to bring it to market. Licensing the technology to an existing business may sometimes provide a more efficient route to commercialisation. **7\. What intellectual property does our startup actually have?** Founders sometimes think of intellectual property as synonymous with patents, particularly when their businesses emerge from scientific or technical research. In reality, a startup's valuable intangible assets may include software copyright, patentable inventions, confidential algorithms, technical know-how, registered designs, trade marks, proprietary documentation and contractual rights to use datasets or research materials. Not all of these assets can be registered, and not all should be protected the same way. Some may depend on confidentiality, contractual restrictions or carefully managed access rather than statutory monopoly rights. The practical starting point is an intellectual property audit that identifies what exists, who owns it, what rights the company has to use it, whether third-party permissions are required, and how each asset contributes to the commercial opportunity. This exercise can also uncover weaknesses that would otherwise emerge during investor due diligence, including missing contractor assignments, uncertain ownership of jointly developed technology or restrictions attached to externally funded research. **8\. Are we reinventing the wheel?** Researchers naturally concentrate on whether their work makes an original scientific or technical contribution. But novelty in a research context does not necessarily establish that the proposed commercial solution is new, commercially attractive or unavailable through existing technologies. Searching patent databases, academic publications, technical repositories and competing products can reveal technologies that overlap with a proposed invention. It may also identify expired patents, potentially licensable technologies, existing software components and alternative approaches that reduce development costs. These searches serve different purposes. Prior-art searches help assess patentability, freedom-to-operate searches examine potential infringement risks, and commercial market research investigates whether customers already have satisfactory alternatives. An existing solution does not necessarily eliminate a commercial opportunity. A new entrant may succeed through lower costs, superior usability, better integration or a more effective distribution model, but founders should understand precisely where their proposed advantage lies. **9\. Our startup has very little money. How can we afford to protect intellectual property?** For university spinouts, this may be the most immediate concern. Patent drafting, prosecution, overseas filings, and enforcement can be expensive, especially when the business has not yet established reliable revenue. The answer is not necessarily to postpone protection until the company can afford a comprehensive portfolio. Nor is it to pursue every available registration regardless of its likely commercial value. A better approach is to prioritise protection based on each asset's importance, the urgency of securing rights, and the consequences of delay. Some measures, such as documenting ownership, controlling confidential disclosures and conducting preliminary searches, may be relatively inexpensive compared with international patent filing programs. A provisional patent application can sometimes buy time to assess the commercial opportunity before making more substantial filing commitments. However, it must adequately disclose the relevant invention to support a later priority claim, does not itself confer enforceable patent rights and should not be mistaken for a complete or inexpensive patent strategy. University researchers should also explore whether their institution's commercialisation office can assist with protection costs, specialist advice or negotiations with prospective licensees and investors. The availability and terms of that support will depend on the institution and the circumstances of the research. Ultimately, intellectual property spending should be linked to commercial milestones. The decision to invest further in protection should reflect what you've learned about customer demand, market size, technological feasibility, and the value of excluding competitors. **The real challenge is not protecting research. It is creating a commercially defensible business.** These nine questions reveal a recurring theme: successful commercialisation requires more than scientific novelty and intellectual property registration. It demands a coherent relationship between ownership, legal protection, market access, commercial capability and the allocation of scarce resources. A startup may have an impressive patent portfolio but lack the necessary commercial rights to exploit its technology. Another may own its software outright but fail because customers see insufficient value in the problem it solves. Conversely, a business with relatively modest registered intellectual property may develop a substantial competitive advantage through specialist expertise, confidential know-how, customer relationships and effective execution. For founders emerging from universities, the most important question is therefore not simply, *"How do we protect our invention?"* It is **"What must we own or control, what must we be free to do, and what capabilities must we develop to turn this research into a viable business?"** Answering that question early can prevent a promising research project from becoming a business constrained by the very legal and commercial arrangements intended to support it.